MAPK8 and neoplasm: The mechanism underlying the anti-tumor effect of pristimerin involves in cell cycle arrest, apoptosis, necrosis and autophagy that regulated by ROS/ASK1/JNK, HIF-1α, NF-κB signaling pathway28,33,34,40.